CN1850190A - Rhinitis ointment and preparation method thereof - Google Patents
Rhinitis ointment and preparation method thereof Download PDFInfo
- Publication number
- CN1850190A CN1850190A CN 200610018417 CN200610018417A CN1850190A CN 1850190 A CN1850190 A CN 1850190A CN 200610018417 CN200610018417 CN 200610018417 CN 200610018417 A CN200610018417 A CN 200610018417A CN 1850190 A CN1850190 A CN 1850190A
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- ointment
- vaseline
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 35
- 239000002674 ointment Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims description 8
- 229940099259 vaseline Drugs 0.000 claims abstract description 22
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 16
- 241000628997 Flos Species 0.000 claims abstract description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 6
- 239000009670 cang er zi wan Substances 0.000 claims abstract description 6
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 229940034610 toothpaste Drugs 0.000 claims 1
- 239000000606 toothpaste Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 206010028748 Nasal obstruction Diseases 0.000 abstract description 9
- 206010039101 Rhinorrhoea Diseases 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 208000036071 Rhinorrhea Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 6
- 208000000592 Nasal Polyps Diseases 0.000 description 6
- 206010039088 Rhinitis atrophic Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000003928 nasal cavity Anatomy 0.000 description 6
- 208000016366 nasal cavity polyp Diseases 0.000 description 6
- 206010039085 Rhinitis allergic Diseases 0.000 description 5
- 201000010105 allergic rhinitis Diseases 0.000 description 5
- 201000009151 chronic rhinitis Diseases 0.000 description 5
- 210000002850 nasal mucosa Anatomy 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 201000009890 sinusitis Diseases 0.000 description 5
- 206010003694 Atrophy Diseases 0.000 description 4
- 206010020565 Hyperaemia Diseases 0.000 description 4
- 241000545442 Radix Species 0.000 description 4
- 230000037444 atrophy Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 208000010753 nasal discharge Diseases 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000218378 Magnolia Species 0.000 description 2
- 241001180876 Saposhnikovia Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003695 paranasal sinus Anatomy 0.000 description 2
- 210000001944 turbinate Anatomy 0.000 description 2
- 206010002653 Anosmia Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010050515 Hyposmia Diseases 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000019559 hyposmia Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 208000027765 speech disease Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A rhinitis ointment comprises herba Centipedae, flos Magnoliae, fructus Xanthii, radix Angelicae Dahuricae, herba Houttuyniae, ramulus Cinnamomi, rhizoma Ligustici Chuanxiong, herba Schizonepetae, radix Saposhnikoviae, herba Cephalanoploris, radix Platycodi, folium Perillae, herba Senecionis Scandentis, rhizoma Polygoni Cuspidati, fructus Lipuidambaris, radix Linderae, folium Artemisiae Argyi, herba asari, radix aucklandiae, fructus Gardeniae, Poria, and Borneolum Syntheticum, and vaseline is used as concocting ointment. Has obvious curative effect, and can quickly dredge nasal obstruction, inhibit rhinorrhea, eliminate inflammation and restore smell.
Description
Technical field
The present invention relates to Chinese medicine, particularly ointment for treating rhinitis and preparation method thereof.
Background technology
Existing ointment for treating rhinitis, the prescription and the manufacture method that relate to a kind of rhinitis ointment and phinamide as Chinese patent application numbers 96118645.3, it is after Hibisci Mutabilis, the Radix Angelicae Dahuricae, Myriogyne minuta, rhinitis grass are mixed by certain prescription, and through cold sterilization and pulverize, then redistillation is a liquid.Above-mentioned medicament for treating rhinitis is pure Chinese herbal medicine, and it to the curative effect of various rhinitis not clearly and does not all have the essence effect, only cures the symptoms, not the disease, and condition of illness also has more and more serious trend.
Summary of the invention
The purpose of this invention is to provide a kind of ointment for treating rhinitis that promptly takes stopgap measures and effect a permanent cure and preparation method thereof.
A kind of ointment for treating rhinitis of the present invention is made up of Herba Centipedae, Flos Magnoliae, Fructus Xanthii, the Radix Angelicae Dahuricae, Herba Houttuyniae, Ramulus Cinnamomi, Rhizoma Chuanxiong, Herba Schizonepetae, Radix Saposhnikoviae, Herba Cirsii, Radix Platycodonis, Folium Perillae, Herba Senecionis Scandentis, Rhizoma Polygoni Cuspidati, Fructus Liquidambaris, the Radix Linderae, Folium Artemisiae Argyi, Herba Asari, the Radix Aucklandiae, Fructus Gardeniae, Poria, Borneolum Syntheticum, and makes to transfer the usefulness of cream with vaseline.Above component is by weight: Herba Centipedae 10--20 part, Flos Magnoliae 5--15 part, Fructus Xanthii 5--15 part, Radix Angelicae Dahuricae 5--10 part, Herba Houttuyniae 5--10 part, Ramulus Cinnamomi 1--6 part, Rhizoma Chuanxiong 5--10 part, Herba Schizonepetae 1--6 part, Radix Saposhnikoviae 1--6 part, Herba Cirsii 1--6 part, Radix Platycodonis 1--6 part, Folium Perillae 5--10 part, Herba Senecionis Scandentis 1--6 part, Rhizoma Polygoni Cuspidati 1--6 part, Fructus Liquidambaris 1--6 part, Radix Linderae 5--10 part, Folium Artemisiae Argyi 1--6 part, Herba Asari 1--6 part, Radix Aucklandiae 1--6 part, Fructus Gardeniae 1--6 part, Poria 5--10 part, Borneolum Syntheticum 5--10 part, vaseline 10--20 part.
The main flow process of ointment for treating rhinitis production technology of the present invention is as follows:
1 batching: it is qualified to go up processing of medical material by prescription, and weighing is assorted, and Borneolum Syntheticum, vaseline list are put.
2 pulverize to mix: the Chinese crude drug that will remove in will fill a prescription except Borneolum Syntheticum, the vaseline is ground into coarser powder, grinds into fine powder again, and Borneolum Syntheticum grinds into fine powder separately, and mistake 100-120 mesh sieve is with the fine powder medical material mix homogeneously that sieves.
3 one-tenth cream: earlier vaseline is suitably heated, littleization gets final product, and all mixture added among the vaseline again, mixes well, and cooling promptly.
4 preparations: the ointment dosage form that can be made into the same profile of Dens Elephatis cream; Or make bottle or resemble the ointment dosage form of Cooling ointment box sample.
The using method of a kind of ointment for treating rhinitis of the present invention is external.Every day 2-3 time, be coated with and put on the skin around the nasal cavity mucosa.
Ointment for treating rhinitis be the inventor according to the Chinese medicine principle, the Chinese medicine external-applied ointment of autonomous innovation development.Various rhinitis symptoms such as all acute chronic rhinitiss, allergic rhinitis, atrophic rhinitis, sinusitis, nasal polyp, nasal obstruction watery nasal discharge, hyposmia, nasal mucosa hyperemia or dry atrophy are the medication indication.The author since two thousand amounts to 323 routine rhinitis patients with this Ointment in Treatment, all receives significant curative effect.This product has following advantage, and 1, be according to the Chinese medicine principle, have specially good effect, compare with present external remedy for treating rhinitis, curative effect is obvious, and 2, attending scope is acute and chronic rhinitis, sinusitis, allergic rhinitis, symptoms such as atrophic rhinitis, nasal polyp, nasal obstruction, baryo,dmia; 3, effect characteristic: use to be coated with nasal cavity in this cream and to control the rhinitis good effect, can rapid unimpeded nasal obstruction, suppress rhinorrhea, diminish inflammation, recover olfactory sensation.
Now that clinical report is as follows:
One, clinical data
Treat 323 routine patients altogether, male's 226 examples wherein, women 97 examples.Sick type: acute rhinitis 77 examples, chronic rhinitis 101 examples, allergic rhinitis 32 examples, atrophic rhinitis's 31 examples, sinusitis 57 examples, nasal polyp 25 examples, maximum 73 years old age, minimal ages 17 years old, mean age 45.6 years old.The course of disease is the longest 30 years, and is the shortest 15 days.
Two, medicine is formed and usage
See the foregoing invention content.
Three, observation of curative effect
" diagnostic criteria of traditional Chinese medical science disease " according to diagnostic criteria and the State Administration of Traditional Chinese Medicine promulgation in 1994 of " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " of the 1994-06-28 of State Administration of Traditional Chinese Medicine issue makes a definite diagnosis.
Criterion of therapeutical effect is:
1, acute rhinitis (names of disease of tcm: cold, nasal obstruction): cure: whole body and local symptom and sign disappear; Take a turn for the better: whole body and local symptom and sign are obviously improved; Do not heal: symptom and sign do not have obvious improvement.2, chronic rhinitis (names of disease of tcm: stuffy nose): cure: transference cures such as nasal obstruction, watery nasal discharge, nasal cavity inspection; Check and take a turn for the better: sxs such as nasal obstruction, watery nasal discharge, local sign is obviously improved; Do not heal: sings and symptoms does not have obvious improvement.3, (names of disease of tcm: allergic rhinitis): cure: symptom, sign disappear allergic rhinitis, do not have recurrence more than 3 months; Take a turn for the better: symptom, sign alleviate during outbreak, and attack times reduces; More symptom and Signs do not have obvious improvement.4, the atrophic rhinitis (names of disease of tcm: atrophic rhinitis): cure: transference cure such as dry no tears in the nose, nasal mucosa and concha nasalis recover normally; Take a turn for the better: dry symptom and atrophy of nasal turbinates alleviate in the nose; Do not heal: sings and symptoms obviously improves; 5, sinusitis (names of disease of tcm: nasal sinusitis): cure: transference cure, X line nasal sinuses sheet is no abnormal; Take a turn for the better: symptom is obviously improved, and the nasal cavity inspection sees that performances such as hyperemia, mucosa swelling alleviate.X line nasal sinuses is taken the photograph sheet and is had clear improvement.Do not heal: symptom and sign do not have improvement.6, nasal polyp: cure: nasal polyp disappears; Take a turn for the better: nasal polyp persistence nasal obstruction is obviously improved, and nasal meatus begins comfortable, and closed rhinolalia reduces; Do not heal: symptom and sign do not have improvement.
Four, therapeutic outcome
Clinical 323 routine cacorhinia patients, through using rhinitis ointment of the present invention: A recovery from illness: 3 courses of treatment of medication, be 10 days 1 course of treatment.All all cure, cure rate 100% is wherein cured 145 examples 1 course of treatment, cures 178 examples 2-3 the course of treatment.B takes a turn for the better: medication 2--5 days, and improvement rate 100%.C is invalid: do not have, follow up a case by regular visits to 79 examples after 2 years, recur 2 examples, but symptom alleviates before than treatment, through medication 5-10 days and accuse recovery from illness once more.
Specific embodiment
Embodiment 1
Surplus certain man 37 years old, the cadre suffered from chronic rhinitis 15 years.Examine and see bilateral nostril mucous hyperemia, one meets temperature descends and promptly has a stuffy nose, flows sticking tears, dehisces when sleep night to give vent to anger, and does not know good and foul smellsly, and the treatment of Chinese and western medicine medicine does not all have the essence effect in many ways for many years, and only cures the symptoms, not the disease, and condition of illness has more and more serious trend.After use ointment for treating rhinitis of the present invention upon somebody's introduction, form 12 parts of Herba Centipedae, 7 parts of Flos Magnoliaes, 12 parts of Fructus Xanthii, 6 parts of the Radixs Angelicae Dahuricae, 8 parts of Herba Houttuyniae, 5 parts of Ramulus Cinnamomi, 7 parts of Rhizoma Chuanxiongs, 2 parts of Herba Schizonepetae, 3 parts of Radix Saposhnikoviaes, 3 parts of Herba Cirsiis, 2 parts of Radix Platycodoniss, 2 parts of Folium Perillae, 3 parts of Herba Senecionis Scandentiss, 2 parts of Rhizoma Polygoni Cuspidati, 2 parts of Fructus Liquidambaris, 8 parts of the Radixs Linderae, 2 parts of Folium Artemisiae Argyis, 2 parts of Herba Asaris, 4 parts of the Radix Aucklandiae, 2 parts of Fructus Gardeniae, 7 parts in Poria, 8 parts of Borneolum Syntheticums, 18 parts in vaseline by weight by following component.The main flow process of ointment for treating rhinitis production technology is as follows:
1 batching: it is qualified to go up processing of medical material by prescription, and weighing is assorted, and Borneolum Syntheticum, vaseline list are put.
2 pulverize to mix: the Chinese crude drug that will remove in will fill a prescription except Borneolum Syntheticum, the vaseline is ground into coarser powder, grinds into fine powder again, and Borneolum Syntheticum grinds into fine powder separately, and mistake 100 mesh sieves are with the fine powder medical material mix homogeneously that sieves.
3 one-tenth cream: earlier vaseline is suitably heated, littleization gets final product, and all mixture added among the vaseline again, mixes well, and cooling promptly.
4 preparations: make bottle or resemble the ointment dosage form of Cooling ointment box sample.
The using method of a kind of ointment for treating rhinitis of the present invention is external.Every day 3 times, be coated with and put on the skin around the nasal cavity mucosa.
Check after one course of treatment: nasal mucosa hyperemia, the sticking white tears of stream disappear, and nasal obstruction is clearly better, and is continuous with after the course of treatment, hear suddenly that when once having a dinner fragrance scurries nose, and surplus card removes to the greatest extent, follows up a case by regular visits to after 2 years not have to recur.
Embodiment 2
Woman Liu 39 years old sells books and periodicals, suffers from the atrophic rhinitis 6 years.Examine and see the dry atrophy of bilateral nasal mucosa, the tears crust accumulates, and nasal cavity is itched sometimes, does not know good and foul smells.Allegedly once arrived city, the diagnosis and treatment of provincial hospital department of eye, heavy when light during symptom during medication, bounce-back recurrence again after the drug withdrawal.
After use ointment for treating rhinitis of the present invention upon somebody's introduction, form 13 parts of Herba Centipedae, 6 parts of Flos Magnoliaes, 11 parts of Fructus Xanthii, 7 parts of the Radixs Angelicae Dahuricae, 9 parts of Herba Houttuyniae, 5 parts of Ramulus Cinnamomi, 6 parts of Rhizoma Chuanxiongs, 1 part of Herba Schizonepetae, 4 parts of Radix Saposhnikoviaes, 3 parts of Herba Cirsiis, 2 parts of Radix Platycodoniss, 2 parts of Folium Perillae, 3 parts of Herba Senecionis Scandentiss, 2 parts of Rhizoma Polygoni Cuspidati, 2 parts of Fructus Liquidambaris, 8 parts of the Radixs Linderae, 2 parts of Folium Artemisiae Argyis, 2 parts of Herba Asaris, 3 parts of the Radix Aucklandiae, 2 parts of Fructus Gardeniae, 7 parts in Poria, 9 parts of Borneolum Syntheticums, 18 parts in vaseline by weight by following component.The main flow process of ointment for treating rhinitis production technology is as follows:
1 batching: it is qualified to go up processing of medical material by prescription, and weighing is assorted, and Borneolum Syntheticum, vaseline list are put.
2 pulverize to mix: the Chinese crude drug that will remove in will fill a prescription except Borneolum Syntheticum, the vaseline is ground into coarser powder, grinds into fine powder again, and Borneolum Syntheticum grinds into fine powder separately, and mistake 120 mesh sieves are with the fine powder medical material mix homogeneously that sieves.
3 one-tenth cream: earlier vaseline is suitably heated, littleization gets final product, and all mixture added among the vaseline again, mixes well, and cooling promptly.
4 preparations: the ointment dosage form of making the same profile of Dens Elephatis cream.
After check after one course of treatment with ointment for treating rhinitis, the dry atrophy of nasal mucosa takes a turn for the better, and littlely knows good and foul smellsly, and i.e. recovery from illness after with a course of treatment requires check not have again and recurs after 5 months.
Claims (2)
1, a kind of ointment for treating rhinitis is made of by weight following component: Herba Centipedae 10--20 part, Flos Magnoliae 5--15 part, Fructus Xanthii 5--15 part, Radix Angelicae Dahuricae 5--10 part, Herba Houttuyniae 5--10 part, Ramulus Cinnamomi 1--6 part, Rhizoma Chuanxiong 5--10 part, Herba Schizonepetae 1--6 part, Radix Saposhnikoviae 1--6 part, Herba Cirsii 1--6 part, Radix Platycodonis 1--6 part, Folium Perillae 5--10 part, Herba Senecionis Scandentis 1--6 part, Rhizoma Polygoni Cuspidati 1--6 part, Fructus Liquidambaris 1--6 part, Radix Linderae 5--10 part, Folium Artemisiae Argyi 1--6 part, Herba Asari 1--6 part, Radix Aucklandiae 1--6 part, Fructus Gardeniae 1--6 part, Poria 5--10 part, Borneolum Syntheticum 5--10 part, vaseline 10--20 part.
2, a kind of ointment for treating rhinitis production technology as claimed in claim 1 is characterized in that:
(1) batching: go up processing of medical material by claim 1 prescription, weighing is assorted, and Borneolum Syntheticum, vaseline list are put,
(2) pulverize to mix: the Chinese crude drug that will remove in will fill a prescription except Borneolum Syntheticum, the vaseline is ground into coarser powder, grinds into fine powder again, and Borneolum Syntheticum grinds into fine powder separately, mistake 100-120 mesh sieve, and with the fine powder medical material mix homogeneously that sieves,
(3) become cream: earlier vaseline is suitably heated, littleization gets final product, and all mixture added among the vaseline again, mixes well, cool off promptly,
(4) preparation: can be made into ointment dosage form as the toothpaste profile; Or make bottle or resemble the ointment dosage form of Cooling ointment box sample.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100184176A CN100393338C (en) | 2006-02-24 | 2006-02-24 | Rhinitis ointment and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100184176A CN100393338C (en) | 2006-02-24 | 2006-02-24 | Rhinitis ointment and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1850190A true CN1850190A (en) | 2006-10-25 |
| CN100393338C CN100393338C (en) | 2008-06-11 |
Family
ID=37131702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100184176A Expired - Fee Related CN100393338C (en) | 2006-02-24 | 2006-02-24 | Rhinitis ointment and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100393338C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301337B (en) * | 2008-06-03 | 2011-09-21 | 陈德顺 | Chinese medicine preparation for treating hepatic cirrhosis induced haematemesis |
| CN102488746A (en) * | 2011-12-28 | 2012-06-13 | 青岛绿曼生物工程有限公司 | Compound propolis composition for treating swine infectious atrophic rhinitis and preparation method thereof |
| CN105194103A (en) * | 2015-11-06 | 2015-12-30 | 黄秋丽 | Rhinitis cream and preparation method thereof |
| CN106038703A (en) * | 2016-07-29 | 2016-10-26 | 吴强 | Traditional Chinese medicine ointment for treating nasosinusitis and preparation method thereof |
| CN107375422A (en) * | 2017-08-11 | 2017-11-24 | 重庆市中医院 | Treatment part catarrh symptom liniment and preparation method thereof |
| CN107582708A (en) * | 2017-09-22 | 2018-01-16 | 简惠泉 | A kind of Chinese traditional medicine composition preparation for preventing and treating rhinitis and preparation method thereof |
| CN110946952A (en) * | 2019-12-25 | 2020-04-03 | 北京辨证堂中医药研究院 | Pure traditional Chinese medicine rhinitis ointment for treating allergic rhinitis, nasosinusitis and nasal polyp |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102319411A (en) * | 2011-09-22 | 2012-01-18 | 黄馨莹 | A kind of medicine of treating sinusitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166388C (en) * | 2002-01-18 | 2004-09-15 | 陈炳南 | Medicine for treating nosal inflammation |
-
2006
- 2006-02-24 CN CNB2006100184176A patent/CN100393338C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301337B (en) * | 2008-06-03 | 2011-09-21 | 陈德顺 | Chinese medicine preparation for treating hepatic cirrhosis induced haematemesis |
| CN102488746A (en) * | 2011-12-28 | 2012-06-13 | 青岛绿曼生物工程有限公司 | Compound propolis composition for treating swine infectious atrophic rhinitis and preparation method thereof |
| CN102488746B (en) * | 2011-12-28 | 2014-05-28 | 青岛绿曼生物工程有限公司 | Compound propolis composition for treating swine infectious atrophic rhinitis and preparation method thereof |
| CN105194103A (en) * | 2015-11-06 | 2015-12-30 | 黄秋丽 | Rhinitis cream and preparation method thereof |
| CN106038703A (en) * | 2016-07-29 | 2016-10-26 | 吴强 | Traditional Chinese medicine ointment for treating nasosinusitis and preparation method thereof |
| CN107375422A (en) * | 2017-08-11 | 2017-11-24 | 重庆市中医院 | Treatment part catarrh symptom liniment and preparation method thereof |
| CN107582708A (en) * | 2017-09-22 | 2018-01-16 | 简惠泉 | A kind of Chinese traditional medicine composition preparation for preventing and treating rhinitis and preparation method thereof |
| CN110946952A (en) * | 2019-12-25 | 2020-04-03 | 北京辨证堂中医药研究院 | Pure traditional Chinese medicine rhinitis ointment for treating allergic rhinitis, nasosinusitis and nasal polyp |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100393338C (en) | 2008-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100393338C (en) | Rhinitis ointment and preparation method thereof | |
| CN1899406A (en) | Chinese medicinal powder for treating rhinitis and its preparing method | |
| CN101810739B (en) | Anti-osteoarthritis Chinese medicament compound and use thereof | |
| CN104042767B (en) | A kind of pharmaceutical composition for the treatment of chronic pharyngitis and its production and use | |
| CN1839953A (en) | Medicine for treating idiopathy thrombocytopenia peliosis | |
| CN101791385A (en) | Medicine for treating psoriasis | |
| CN1117582C (en) | medicine for treating rheumatoid arthritis and preparing process thereof | |
| CN1128633C (en) | Exterior-applied medicine for treating gynopathy | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN101164576B (en) | Traditional Chinese medicine for treating woman pelvic inflammation and adnexa disease and its preparing technology | |
| CN104491459A (en) | Traditional Chinese medicine composition for treating tumors | |
| CN102885961B (en) | Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine | |
| CN102058837A (en) | Medicament for treating exfetation and preparation method thereof | |
| CN101732424B (en) | Chinese medicinal powder for treating pharyngitis | |
| CN1965980A (en) | Quick-acting vagina shrinking agent and method for preparing same | |
| CN1364608A (en) | Powder for curing gout | |
| CN104666651B (en) | A kind of medicament for the treatment of cervical hypertrophy | |
| CN1296830A (en) | Chinese-medicinal capsule for treating diabetes | |
| CN1088370C (en) | Tongguanshugan ointment and preparation process thereof | |
| CN100364596C (en) | Compounded mongolia medicine for treating diabetes and preparing method | |
| CN116270839B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and ankylosing spondylitis as well as preparation method and application thereof | |
| CN101732606B (en) | Oral medicinal composition for treating psoriasis | |
| CN101327283B (en) | Composite medicine for treating nephrosis and its preparing process | |
| CN1265908A (en) | Cough-relieving medicine | |
| CN101757137A (en) | Medication for treating mixed hemorrhoids and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080611 Termination date: 20130224 |